DexCom Revenue 2010-2023 | DXCM
DexCom annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- DexCom revenue for the quarter ending December 31, 2023 was $1.035B, a 26.9% increase year-over-year.
- DexCom revenue for the twelve months ending December 31, 2023 was $3.622B, a 24.49% increase year-over-year.
- DexCom annual revenue for 2023 was $3.622B, a 24.49% increase from 2022.
- DexCom annual revenue for 2022 was $2.91B, a 18.84% increase from 2021.
- DexCom annual revenue for 2021 was $2.449B, a 27.08% increase from 2020.
| DexCom Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $3,622 |
| 2022 | $2,910 |
| 2021 | $2,449 |
| 2020 | $1,927 |
| 2019 | $1,476 |
| 2018 | $1,032 |
| 2017 | $719 |
| 2016 | $573 |
| 2015 | $402 |
| 2014 | $259 |
| 2013 | $160 |
| 2012 | $100 |
| 2011 | $76 |
| 2010 | $49 |
| 2009 | $30 |
| DexCom Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,035 |
| 2023-09-30 | $975 |
| 2023-06-30 | $871 |
| 2023-03-31 | $742 |
| 2022-12-31 | $815 |
| 2022-09-30 | $770 |
| 2022-06-30 | $696 |
| 2022-03-31 | $629 |
| 2021-12-31 | $698 |
| 2021-09-30 | $650 |
| 2021-06-30 | $595 |
| 2021-03-31 | $505 |
| 2020-12-31 | $569 |
| 2020-09-30 | $501 |
| 2020-06-30 | $452 |
| 2020-03-31 | $405 |
| 2019-12-31 | $463 |
| 2019-09-30 | $396 |
| 2019-06-30 | $336 |
| 2019-03-31 | $281 |
| 2018-12-31 | $338 |
| 2018-09-30 | $267 |
| 2018-06-30 | $243 |
| 2018-03-31 | $184 |
| 2017-12-31 | $221 |
| 2017-09-30 | $185 |
| 2017-06-30 | $171 |
| 2017-03-31 | $142 |
| 2016-12-31 | $171 |
| 2016-09-30 | $149 |
| 2016-06-30 | $137 |
| 2016-03-31 | $116 |
| 2015-12-31 | $131 |
| 2015-09-30 | $105 |
| 2015-06-30 | $93 |
| 2015-03-31 | $73 |
| 2014-12-31 | $84 |
| 2014-09-30 | $69 |
| 2014-06-30 | $59 |
| 2014-03-31 | $47 |
| 2013-12-31 | $52 |
| 2013-09-30 | $43 |
| 2013-06-30 | $36 |
| 2013-03-31 | $30 |
| 2012-12-31 | $33 |
| 2012-09-30 | $23 |
| 2012-06-30 | $23 |
| 2012-03-31 | $20 |
| 2011-12-31 | $22 |
| 2011-09-30 | $18 |
| 2011-06-30 | $21 |
| 2011-03-31 | $14 |
| 2010-12-31 | $16 |
| 2010-09-30 | $12 |
| 2010-06-30 | $12 |
| 2010-03-31 | $10 |
| 2009-12-31 | $10 |
| 2009-09-30 | $7 |
| 2009-06-30 | $7 |
| 2009-03-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $51.051B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.485B | 26.48 |
| Intuitive Surgical (ISRG) | United States | $135.271B | 81.49 |
| Edwards Lifesciences (EW) | United States | $51.372B | 33.43 |
| IQVIA Holdings (IQV) | United States | $40.698B | 23.61 |
| IDEXX Laboratories (IDXX) | United States | $39.691B | 46.53 |
| Alcon (ALC) | Switzerland | $39.236B | 28.93 |
| STERIS (STE) | Ireland | $20.536B | 24.31 |
| Waters (WAT) | United States | $19.053B | 27.34 |
| Hologic (HOLX) | United States | $17.966B | 19.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.387B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.392B | 85.37 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.306B | 15.20 |
| Sysmex ADR (SSMXY) | Japan | $10.920B | 34.24 |
| Teleflex (TFX) | United States | $9.562B | 14.88 |
| Penumbra (PEN) | United States | $8.083B | 99.79 |
| Masimo (MASI) | United States | $7.249B | 40.65 |
| Globus Medical (GMED) | United States | $7.033B | 22.30 |
| Glaukos (GKOS) | United States | $5.346B | 0.00 |
| TransMedics (TMDX) | United States | $4.216B | 399.97 |
| Integer Holdings (ITGR) | United States | $3.728B | 22.52 |
| LivaNova (LIVN) | United Kingdom | $3.474B | 20.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.307B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.888B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.712B | 18.60 |
| Nihon Kohden (NHNKY) | Japan | $2.490B | 21.06 |
| Inari Medical (NARI) | United States | $2.444B | 0.00 |
| RxSight (RXST) | United States | $2.281B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.271B | 9.32 |
| Alphatec Holdings (ATEC) | United States | $1.908B | 0.00 |
| Veracyte (VCYT) | United States | $1.556B | 0.00 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.903B | 17.57 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| Artivion (AORT) | United States | $0.862B | 99.67 |
| Silk Road Medical (SILK) | United States | $0.800B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.781B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.679B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.623B | 21.15 |
| SiBone (SIBN) | United States | $0.585B | 0.00 |
| IRadimed (IRMD) | United States | $0.566B | 31.70 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.509B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.498B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.432B | 0.00 |
| Nevro (NVRO) | United States | $0.414B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
| Sight Sciences (SGHT) | United States | $0.295B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| AxoGen (AXGN) | United States | $0.253B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.199B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.23 |
| 908 Devices (MASS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Accuray (ARAY) | United States | $0.161B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.159B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.154B | 0.00 |
| Neuronetics (STIM) | United States | $0.114B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.085B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.061B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.060B | 121.67 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |